Australia, Sept. 17 -- PRIOVANT THERAPEUTICS Inc., owns the trademark (2668055) for 'LISRAYA' till April 20, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease.]
Type of Mark: Word
Date of Acceptance: July 9
Registration Advertised: Sept. 16
For further details contact S.C. Lisa L. Mueller Casimir Jones.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2668055.
Disclaimer: Curated by HT Syndication.
